Risk‐based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019
暂无分享,去创建一个
J. Baeten | B. Richardson | G. John-Stewart | Anjuli D. Wagner | J. Pintye | Felix Abuna | J. Kinuthia | Ben Ochieng | Joshua Stern | Mary M Marwa | Salphine Watoyi | J. Dettinger | Mary Marwa | Lauren Gomez | Daniel Odinga | Nancy Ngumbau | A. Wagner
[1] I. Speizer,et al. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa , 2022, BMC Public Health.
[2] J. Baeten,et al. “PrEP Gives the Woman the Control”: Healthcare Worker Perspectives on Using pre-Exposure Prophylaxis (PrEP) During Pregnancy and Postpartum in Kenya , 2022, Journal of the International Association of Providers of AIDS Care.
[3] Gabrielle E. O'Malley,et al. Brief Report: “What Is This PrEP?”—Sources and Accuracy of HIV Pre-Exposure Prophylaxis (PrEP) Awareness Among Adolescent Girls and Young Women Attending Family Planning and Maternal Child Health Clinics in Western Kenya , 2021, Journal of acquired immune deficiency syndromes.
[4] L. Myer,et al. “I had Made the Decision, and No One was Going to Stop Me” —Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa , 2021, AIDS and Behavior.
[5] V. Frye,et al. Women’s views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention , 2021, Culture, health & sexuality.
[6] Gabrielle E. O'Malley,et al. Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program. , 2020, Journal of acquired immune deficiency syndromes.
[7] L. Myer,et al. 'I had made the decision, and no one was going to stop me': Facilitators of PrEP adherence during pregnancy and postpartum in Cape Town, South Africa , 2020, medRxiv.
[8] J. Schneider,et al. A taxonomy of pragmatic measures of HIV preexposure prophylaxis use. , 2020, AIDS.
[9] B. Chi,et al. Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework. , 2020, The lancet. HIV.
[10] J. Schneider,et al. A taxonomy of pragmatic measures of HIV pre-exposure prophylaxis (PrEP) Use: application in a PrEP-using cohort in Chicago, IL. , 2020, AIDS.
[11] J. Baeten,et al. Challenges of discrepant HIV tests in pregnant women in the PrEP era - to treat or not to treat? , 2020, The Journal of infectious diseases.
[12] B. Chi,et al. Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis. , 2020, AIDS.
[13] J. Baeten,et al. Frequency and predictors of tenofovir-diphosphate detection among young Kenyan women in a real-world pre-exposure prophylaxis implementation program. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] B. Chi,et al. Incident HIV among pregnant and breastfeeding women in sub-Saharan Africa: a systematic review and meta-analysis. , 2020, AIDS (London).
[15] B. Chi,et al. Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? , 2020, Journal of the International AIDS Society.
[16] J. Baeten,et al. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. , 2019, The lancet. HIV.
[17] J. Baeten,et al. Perinatal outcomes following maternal pre‐exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya , 2019, Journal of the International AIDS Society.
[18] J. Baeten,et al. A field evaluation of point-of-care creatinine testing within a large PrEP implementation program in Western Kenya. , 2019, Journal of acquired immune deficiency syndromes.
[19] Danya E Keene,et al. Social Networks and Its Impact on Women's Awareness, Interest, and Uptake of HIV Pre-exposure Prophylaxis (PrEP): Implications for Women Experiencing Intimate Partner Violence , 2019, Journal of acquired immune deficiency syndromes.
[20] Gabrielle E. O'Malley,et al. PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial , 2019, BMJ Open.
[21] Grace John-Stewart,et al. Brief Report: Integration of PrEP Services Into Routine Antenatal and Postnatal Care Experiences From an Implementation Program in Western Kenya , 2018, Journal of acquired immune deficiency syndromes.
[22] J. Baeten,et al. Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners , 2018, The Journal of infectious diseases.
[23] Nicola Lancki,et al. Which Patients in the Emergency Department Should Receive Preexposure Prophylaxis? Implementation of a Predictive Analytics Approach , 2018, AIDS patient care and STDs.
[24] L. Myer,et al. Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier. , 2017, AIDS.
[25] Jennifer A. Unger,et al. A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] J. Baeten,et al. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption , 2016, PLoS medicine.
[27] R. Grant,et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations , 2016, AIDS.
[28] J. Baeten,et al. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women , 2016, Current opinion in HIV and AIDS.
[29] Alison L. Drake,et al. HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics , 2015, AIDS.
[30] N. Shaffer,et al. Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation , 2015, PloS one.
[31] L. van Damme,et al. Perception of HIV Risk and Adherence to a Daily, Investigational Pill for HIV Prevention in FEM-PrEP , 2014, Journal of acquired immune deficiency syndromes.
[32] Alison L. Drake,et al. Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis , 2014, PLoS medicine.
[33] S. Ellington,et al. Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] M. Newell,et al. The Contribution of Maternal HIV Seroconversion During Late Pregnancy and Breastfeeding to Mother-to-Child Transmission of HIV , 2012, Journal of acquired immune deficiency syndromes.
[35] L. Moulton,et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study , 2010, BMJ : British Medical Journal.
[36] S. Lockman,et al. Acute maternal HIV infection during pregnancy and breast-feeding: substantial risk to infants. , 2009, The Journal of infectious diseases.
[37] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[38] R. Spitzer,et al. The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener , 2003, Medical care.
[39] J. Sinacore,et al. HITS: a short domestic violence screening tool for use in a family practice setting. , 1998, Family medicine.